Log in
Enquire now
‌

US Patent 11028422 Process for the production of ultrapure galacto-oligosaccharides

Patent 11028422 was granted and assigned to Ritter Pharmaceuticals on June, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Ritter Pharmaceuticals
Ritter Pharmaceuticals
Current Assignee
Ritter Pharmaceuticals
Ritter Pharmaceuticals
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11028422
Date of Patent
June 8, 2021
Patent Application Number
16153544
Date Filed
October 5, 2018
Patent Primary Examiner
‌
Thomas J Visone
Patent abstract

The present invention describes a process for preparing ultrapure (≥95%) galacto-oligosaccharides (GOS), starting from GOS at lower purities by using sequential microbiological purifications involving Saccharomyces cerevisiae and Streptococcus thermophilus.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11028422 Process for the production of ultrapure galacto-oligosaccharides

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.